Search

everythinglearnresearchcommunity

for

Search:↓

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

UK stem-cell clinics often mislead about treatment safety and effectiveness, needing better regulation.

New understanding and treatments for hair loss are improving, but more research is needed.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Baricitinib is effective and safe for treating severe alopecia areata.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

PLD is an effective and safer alternative for treating breast cancer.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.